NCT03048812

Brief Summary

Dental implants are often the preferred treatment option and in some clinical scenarios they are considered the standard of care to restore missing or damaged teeth, due to the limitations of conventional treatments. For fully edentulous subjects, conventional tissue-supported dentures in some cases are associated with severe subjective complaints and difficult adaptation, mainly the mandibular denture, resulting in limited function and detrimental effects on oral health-related quality of life, especially for older patients. The use of implants to retain a mandibular denture (overdenture) has been recommended as a suitable and low-cost alternative to improve denture stability, with positive effects on oral comfort and function. The two-implant mandibular overdenture has been considered an effective design to achieve clinical benefits for patients. However, the main problem facing two-implant overdenture is the high cost of implantation and the relative complexity of the surgical intervention, so the use of a single midline implant to retain a mandibular overdenture was suggested as a more viable solution for reducing costs and complexity of treatment with similar benefits compared to solutions with higher number of implants. Nevertheless, there are few studies that compared the performance of different retention systems and their effects on patient-centered outcomes, such as satisfaction with the dentures, oral health-related quality of life, individual preferences and other subjective ratings of clinical outcomes. Thus, the aim of this randomized clinical trial with a crossover design is to investigate the changes in clinical and patient-reported outcomes following the use of different retention systems for a single implant-retained mandibular overdenture Hypothesis: it was hypothesized that clinical and patient-reported outcomes of a single-implant mandibular overdenture is dependent on the type of retention system, and patients have distinct preferences in relation to different attachments

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2017

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 6, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 9, 2017

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2018

Completed
Last Updated

September 18, 2018

Status Verified

September 1, 2018

Enrollment Period

1.3 years

First QC Date

February 6, 2017

Last Update Submit

September 17, 2018

Conditions

Keywords

Dental implantMandibular overdentureCross-over study

Outcome Measures

Primary Outcomes (1)

  • Patient preference

    Patient satisfaction with the attachment connected to the single implant overdenture

    3 months

Secondary Outcomes (3)

  • Abutment loosening incidence

    3 months

  • Patient satisfaction

    3 months

  • Need for replacement

    3 months

Study Arms (2)

O'Ring attachment (A)

EXPERIMENTAL

One arm of our research will receive O'Ring attachment for 3 months and after this period they will recieve the second attachment Equator for more 3 months

Device: O'Ring Attachment (A)Device: Equator Attachment (B)

Equator attachment (B)

EXPERIMENTAL

The second arm of our research will receive Equator attachment for 3 months and after this period they will recieve the second attachement O Ring for more 3 months

Device: O'Ring Attachment (A)Device: Equator Attachment (B)

Interventions

Attachment A will be inserted in three months of follow up,followed by treatment B in a random order

Also known as: O'ring (Neodent, Curitiba, Paraná, Brazil)
Equator attachment (B)O'Ring attachment (A)

Attachment B will be inserted in three months of follow up,followed by treatment A in a random order

Also known as: Equator (Neodent, Curitiba, Paraná, Brazil)
Equator attachment (B)O'Ring attachment (A)

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Be completely edentulous, male or female with no age restrictions;
  • Need replacement or confection of new complete dentures defined according to normative criteria and/or own demand;
  • Have no contraindications for implant placement surgery (mainly related to uncontrolled systemic diseases such as diabetes and hypertension);
  • Have enough bone volume in the mandibular midline area for installation of an implant without the need for augmentation procedures;
  • be able to understand and answer to the questionnaires used in the study;
  • agree to participate in this study by providing a written informed consent.

You may not qualify if:

  • present signs that they will be uncompliant in the follow-up appointments;
  • present local conditions that could directly influence stability and/or retention of the dentures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Mouth, Edentulous

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic DiseasesTooth Diseases

Study Officials

  • Claudio R Leles, Doctorate

    UFG

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcome assessment will be blinded for assessment which treatment (O-Ring \\Equator) is provided
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Participants are randomized to the AB sequence receive treatment A in the first period and treatment B in the second period, whereas experimental units that are randomized to the BA sequence receive treatment B in the first period and treatment A in the second period
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 6, 2017

First Posted

February 9, 2017

Study Start

January 1, 2017

Primary Completion

May 1, 2018

Study Completion

August 1, 2018

Last Updated

September 18, 2018

Record last verified: 2018-09

Data Sharing

IPD Sharing
Will not share